⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL230454 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL2329454 | 0.98 | — | — | |
| SCHEMBL27574454 | 0.98 | — | — | |
| SCHEMBL15150021 | 0.78 | — | — | |
| SCHEMBL17627904 | 0.78 | — | — | |
| SCHEMBL15149517 | 0.78 | — | — | |
| SCHEMBL325433 | 0.76 | — | — | |
| SCHEMBL15330716 | 0.76 | — | — | |
| SCHEMBL8183729 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL1703549 | 0.75 | CYP2D6 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2861745-A2 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | Invista Technologies S.à.r.l. (CH) | 2015-04-22 | — | — | EP | claimed |
| EP-2785848-A2 | METHODS FOR BIOSYNTHESIZING 1,3BUTADIENE | INVISTA Technologies S.à.r.l. (CH) | 2014-10-08 | — | — | EP | claimed |
| WO-2013188546-A2 | METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE | INVISTA TECHNOLOGIES S.À.R.L. (CH) | 2013-12-19 | — | — | WO | claimed |
| WO-2013082542-A2 | METHODS FOR BIOSYNTHESIZING 1,3BUTADIENE | INVISTA NORTH AMERICA S.A.R.L. (US) | 2013-06-06 | — | — | WO | claimed |
| EP-4423259-A1 | ENGINEERED ENZYMES AND METHODS OF MAKING AND USING | Genomatica, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| EP-4388319-A1 | PERSONALIZED MODULATION THERAPY FOR CANCER | Faeth Therapeutics, Inc. (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-4277976-A1 | METHODS AND COMPOSITIONS FOR MAKING AMIDE COMPOUNDS | Genomatica, Inc. (US) | 2023-11-22 | — | — | EP | disclosed |
| WO-2023076966-A1 | ENGINEERED ENZYMES AND METHODS OF MAKING AND USING | GENOMATICA, INC. (US) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023023147-A1 | PERSONALIZED MODULATION THERAPY FOR CANCER | FAETH THERAPEUTICS, INC. (US) | 2023-02-23 | — | — | WO | disclosed |
| WO-2022155554-A1 | METHODS AND COMPOSITIONS FOR MAKING AMIDE COMPOUNDS | GENOMATICA, INC. (US) | 2022-07-21 | — | — | WO | disclosed |
| EP-3959310-A1 | ENGINEERED TRANSAMINASE AND METHODS OF MAKING AND USING | Genomatica, Inc. (US) | 2022-03-02 | — | — | EP | disclosed |
| EP-3959327-A1 | ENGINEERED TRANS-ENOYL COA REDUCTASE AND METHODS OF MAKING AND USING | Genomatica, Inc. (US) | 2022-03-02 | — | — | EP | disclosed |
| WO-2012129450-A1 | MICROBIAL PRODUCTION OF CHEMICAL PRODUCTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX BIOTECHNOLOGIES, INC. (US) | 2012-09-27 | — | — | WO | disclosed |
| EP-2459531-A2 | SYNTHESIS AND USE OF VILDAGLIPTIN FOR THE PREPARATION OF PHARMACEUTICAL DOSAGE FORMS | KRKA, D.D., Novo Mesto (SI) | 2012-06-06 | — | — | EP | disclosed |
| EP-2427544-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | Genomatica, Inc. (US) | 2012-03-14 | — | — | EP | disclosed |
| WO-2011012322-A9 | SYNTHESIS AND USE OF VILDAGLIPTIN FOR THE PREPARATION OF PHARMACEUTICAL DOSAGE FORMS | KRKA, D.D., NOVO MESTO (SI) | 2011-08-11 | — | — | WO | disclosed |
| WO-2011012322-A2 | SYNTHESIS AND USE OF VILDAGLIPTIN FOR THE PREPARATION OF PHARMACEUTICAL DOSAGE FORMS | KRKA, D.D., NOVO MESTO (SI) | 2011-02-03 | — | — | WO | disclosed |
| WO-2010129936-A1 | MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID | GENOMATICA, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| WO-2009052186-A1 | METABOLOMICS-BASED IDENTIFICATION OF DISEASE-CAUSING AGENTS | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-04-23 | — | — | WO | disclosed |
| EP-0931069-B1 | PROCESS FOR PREPARING AMIDINES | BASF AG (DE) | 2000-11-29 | — | — | EP | disclosed |